These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 6472539)
1. High dose of L-carnitine increases platelet aggregation and plasma triglyceride levels in uremic patients on hemodialysis. Weschler A; Aviram M; Levin M; Better OS; Brook JG Nephron; 1984; 38(2):120-4. PubMed ID: 6472539 [TBL] [Abstract][Full Text] [Related]
2. L-carnitine and platelet aggregation in uremic patients subjected to hemodialysis. Bellinghieri G; Savica V; Barbera CM; Ricciardi B; Egitto M; Torre F; Valentini G; D'Iddio S; Bagiella E; Mallamace A Nephron; 1990; 55(1):28-32. PubMed ID: 2141109 [TBL] [Abstract][Full Text] [Related]
3. Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis. Guarnieri GF; Ranieri F; Toigo G; Vasile A; Ciman M; Rizzoli V; Moracchiello M; Campanacci L Am J Clin Nutr; 1980 Jul; 33(7):1489-92. PubMed ID: 7395772 [TBL] [Abstract][Full Text] [Related]
4. Carnitine deficiency induced during hemodialysis and hyperlipidemia: effect of replacement therapy. Bertoli M; Battistella PA; Vergani L; Naso A; Gasparotto ML; Romagnoli GF; Angelini C Am J Clin Nutr; 1981 Aug; 34(8):1496-500. PubMed ID: 7270472 [TBL] [Abstract][Full Text] [Related]
5. [Effects of L-carnitine on erythropoiesis and blood platelet aggregation in patients with chronic renal failure treated with hemodialysis]. Kalinowski M; Popławski A; Mazerska M; Daniluk A Pol Merkur Lekarski; 1999 Feb; 6(32):76-8. PubMed ID: 10337176 [TBL] [Abstract][Full Text] [Related]
6. Carnitine depletion as a probable cause of hyperlipidemia in uremic patients on maintenance hemodialysis. Maebashi M; Imamura A; Yoshinaga K; Sato T; Funyu T; Ishidoya Y; Hirayama N Tohoku J Exp Med; 1983 Jan; 139(1):33-42. PubMed ID: 6836557 [TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
8. Favorable effects of L-carnitine treatment on hypertriglyceridemia in hemodialysis patients: decisive role of low levels of high-density lipoprotein-cholesterol. Vacha GM; Giorcelli G; Siliprandi N; Corsi M Am J Clin Nutr; 1983 Oct; 38(4):532-40. PubMed ID: 6624695 [TBL] [Abstract][Full Text] [Related]
9. Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients. Wanner C; Wieland H; Wäckerle B; Boeckle H; Schollmeyer P; Hörl WH Kidney Int Suppl; 1989 Nov; 27():S264-8. PubMed ID: 2636668 [TBL] [Abstract][Full Text] [Related]
10. [Effects of long-term treatment with L-carnitine on dyslipemia in hemodialysis patients]. Dionisio P; Bergia R; Caramello E; Graziola M; Valenti M; Bajardi P; Barbera L; Voglino F Minerva Med; 1985 Feb; 76(6):229-34. PubMed ID: 3974937 [TBL] [Abstract][Full Text] [Related]
11. Platelet function in patients on maintenance hemodialysis: depressed or enhanced? Remuzzi G; Benigni A; Dodesini P; Schieppati A; Gotti E; Livio M; Mecca G; Donati B; de Gaetano G Clin Nephrol; 1982 Feb; 17(2):60-3. PubMed ID: 7067167 [TBL] [Abstract][Full Text] [Related]
12. Selective deficiency of hepatic triglyceride lipase in uremic patients. Mordasini R; Frey F; Flury W; Klose G; Greten H N Engl J Med; 1977 Dec; 297(25):1362-6. PubMed ID: 200841 [TBL] [Abstract][Full Text] [Related]
13. L-carnitine addition to dialysis fluid. A therapeutic alternative for hemodialysis patients. Vacha GM; Giorcelli G; d'Iddio S; Valentini G; Bagiella E; Procopio A; di Donato S; Ashbrook D; Corsi M Nephron; 1989; 51(2):237-42. PubMed ID: 2915763 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of platelet aggregation disturbances and their relation to treatment in patients with chronic uremia. Komarnicki M; Pietrzak I Int J Artif Organs; 1988 Mar; 11(2):91-4. PubMed ID: 3131259 [TBL] [Abstract][Full Text] [Related]
15. Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects. Golper TA; Wolfson M; Ahmad S; Hirschberg R; Kurtin P; Katz LA; Nicora R; Ashbrook D; Kopple JD Kidney Int; 1990 Nov; 38(5):904-11. PubMed ID: 2266674 [TBL] [Abstract][Full Text] [Related]
16. Treatment of uremic anemia with recombinant erythropoietin also reduces the defects in platelet adhesion and aggregation caused by uremic plasma. Zwaginga JJ; IJsseldijk MJ; de Groot PG; Kooistra M; Vos J; van Es A; Koomans HA; Struyvenberg A; Sixma JJ Thromb Haemost; 1991 Dec; 66(6):638-47. PubMed ID: 1665596 [TBL] [Abstract][Full Text] [Related]
17. Plasma and red blood cell carnitine and carnitine esters during L-carnitine therapy in hemodialysis patients. Wanner C; Wäckerle B; Boeckle H; Schollmeyer P; Hörl WH Am J Clin Nutr; 1990 Mar; 51(3):407-10. PubMed ID: 2309647 [TBL] [Abstract][Full Text] [Related]
18. Carnitine depletion during chronic hemodialysis: effect of substitution on free carnitine plasma levels. Broquet PE; Von Moos C; Frei J; Gobelet C; Wauters JP Adv Exp Med Biol; 1987; 223():287-90. PubMed ID: 3447448 [No Abstract] [Full Text] [Related]
19. Lipid metabolism in non-uremic and uremic dogs during and after hemodialysis with acetate. Morin RJ; Guo LS; Rorke SJ; Davidson WD J Dial; 1978; 2(2):113-29. PubMed ID: 681578 [TBL] [Abstract][Full Text] [Related]
20. Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa. Thekkedath UR; Chirananthavat T; Leypoldt JK; Cheung AK; Mohammad SF Am J Hematol; 2006 Dec; 81(12):915-26. PubMed ID: 16917914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]